Antipodes Partners
TWST icon

Antipodes Partners’s Twist Bioscience TWST Stock Holding History

Antipodes Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24.7K Buy
+128
New +$15.8K ﹤0.01% 135

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Antipodes Partners's TWST Position: Q3 2026 in Review

Antipodes Partners opened a new position in Twist Bioscience (TWST) in Q3 2026: 128 shares worth $24.7K. The stake represents ﹤0.01% of the portfolio and ranks #135 among its holdings.

313 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Antipodes Partners held 128 shares of Twist Bioscience worth $24.7K as of Q3 2026.
  • Twist Bioscience was a new Antipodes Partners position in Q3 2026.
  • Twist Bioscience made up ﹤0.01% of Antipodes Partners's portfolio in Q3 2026, its #135 holding.
  • 313 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Antipodes Partners's 13F filing for Q3 2026, filed 5 Nov 2026.